Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
July 9, 2019
Patent Application Number
16032905
Date Filed
July 11, 2018
Patent Citations Received
Patent Primary Examiner
Patent abstract
Provided herein are compounds according to Formulas (I) or (II) and pharmaceutically acceptable salts thereof, and compositions comprising the same, for use in various methods, including treating cancer, abnormal cellular proliferation, angiogenesis, Alzheimer's disease, lung disease, osteoarthritis, idiopathic pulmonary fibrosis and neurological conditions/disorders/diseases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
